<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37626917</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>16</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>19</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Emerging Role of Kinin B1 Receptor in Persistent Neuroinflammation and Neuropsychiatric Symptoms in Mice Following Recovery from SARS-CoV-2 Infection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2107</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells12162107</ELocationID><Abstract><AbstractText>Evidence suggests that patients with long COVID can experience neuropsychiatric, neurologic, and cognitive symptoms. However, these clinical data are mostly associational studies complicated by confounding variables, thus the mechanisms responsible for persistent symptoms are unknown. Here we establish an animal model of long-lasting effects on the brain by eliciting mild disease in K18-hACE2 mice. Male and female K18-hACE2 mice were infected with 4 &#xd7; 10<sup>3</sup> TCID50 of SARS-CoV-2 and, following recovery from acute infection, were tested in the open field, zero maze, and Y maze, starting 30 days post infection. Following recovery from SARS-CoV-2 infection, K18-hACE2 mice showed the characteristic lung fibrosis associated with SARS-CoV-2 infection, which correlates with increased expression of the pro-inflammatory kinin B1 receptor (B1R). These mice also had elevated expression of B1R and inflammatory markers in the brain and exhibited behavioral alterations such as elevated anxiety and attenuated exploratory behavior. Our data demonstrate that K18-hACE2 mice exhibit persistent effects of SARS-CoV-2 infection on brain tissue, revealing the potential for using this model of high sensitivity to SARS-CoV-2 to investigate mechanisms contributing to long COVID symptoms in at-risk populations. These results further suggest that elevated B1R expression may drive the long-lasting inflammatory response associated with SARS-CoV-2 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sriramula</LastName><ForeName>Srinivas</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9937-1589</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theobald</LastName><ForeName>Drew</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-6534-0909</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parekh</LastName><ForeName>Rohan Umesh</ForeName><Initials>RU</Initials><Identifier Source="ORCID">0000-0002-6552-795X</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akula</LastName><ForeName>Shaw M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Rourke</LastName><ForeName>Dorcas P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Department of Comparative Medicine, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eells</LastName><ForeName>Jeffrey B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Anatomy and Cell Biology, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL153115</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NR010361</GrantID><Acronym>NR</Acronym><Agency>NINR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C045927">K-18 conjugate</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007705">Kinins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000090862" MajorTopicYN="N">Neuroinflammatory Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007705" MajorTopicYN="N">Kinins</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">K18-hACE2 mice</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">kinin B1 receptor</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword></KeywordList><CoiStatement>The authors have declared that no conflict of interest exists.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>28</Day><Hour>7</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37626917</ArticleId><ArticleId IdType="pmc">PMC10453171</ArticleId><ArticleId IdType="doi">10.3390/cells12162107</ArticleId><ArticleId IdType="pii">cells12162107</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Larsen J.R., Martin M.R., Martin J.D., Kuhn P., Hicks J.B. Modeling the Onset of Symptoms of COVID-19. Front. Public Health. 2020;8:473. doi: 10.3389/fpubh.2020.00473.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00473</ArticleId><ArticleId IdType="pmc">PMC7438535</ArticleId><ArticleId IdType="pubmed">32903584</ArticleId></ArticleIdList></Reference><Reference><Citation>Buszko M., Park J.H., Verthelyi D., Sen R., Young H.A., Rosenberg A.S. The dynamic changes in cytokine responses in COVID-19: A snapshot of the current state of knowledge. Nat. Immunol. 2020;21:1146&#x2013;1151. doi: 10.1038/s41590-020-0779-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0779-1</ArticleId><ArticleId IdType="pubmed">32855555</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche J.A., Roche R. A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications. FASEB J. 2020;34:7265&#x2013;7269. doi: 10.1096/fj.202000967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202000967</ArticleId><ArticleId IdType="pmc">PMC7267506</ArticleId><ArticleId IdType="pubmed">32359101</ArticleId></ArticleIdList></Reference><Reference><Citation>Garvin M.R., Alvarez C., Miller J.I., Prates E.T., Walker A.M., Amos B.K., Mast A.E., Justice A., Aronow B., Jacobson D. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. eLife. 2020;9 doi: 10.7554/eLife.59177.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.59177</ArticleId><ArticleId IdType="pmc">PMC7410499</ArticleId><ArticleId IdType="pubmed">32633718</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue J.K., Franko N.M., McCulloch D.J., McDonald D., Magedson A., Wolf C.R., Chu H.Y. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Netw. Open. 2021;4:e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., Lim P.H., Szymanski A.L., Taylor C., DiBiase R.M., Jia D.T., Balabanov R., Ho S.U., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers". Ann. Clin. Transl. Neurol. 2021;8:1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiken S., Sittenfeld L., Dridi H., Liu Y., Liu X., Marks A.R. Alzheimer&#x2019;s-like signaling in brains of COVID-19 patients. Alzheimers Dement. 2022;18:955&#x2013;965. doi: 10.1002/alz.12558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12558</ArticleId><ArticleId IdType="pmc">PMC9011576</ArticleId><ArticleId IdType="pubmed">35112786</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocoros N.M., Svensson E., Szepligeti S.K., Vestergaard S.V., Szentkuti P., Thomsen R.W., Borghammer P., Sorensen H.T., Henderson V.W. Long-term Risk of Parkinson Disease Following Influenza and Other Infections. JAMA Neurol. 2021;78:1461&#x2013;1470. doi: 10.1001/jamaneurol.2021.3895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.3895</ArticleId><ArticleId IdType="pmc">PMC8546623</ArticleId><ArticleId IdType="pubmed">34694344</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigasova D., Nemergut M., Liskova B., Damborsky J. Multi-pathogen infections and Alzheimer&#x2019;s disease. Microb Cell Fact. 2021;20:25. doi: 10.1186/s12934-021-01520-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12934-021-01520-7</ArticleId><ArticleId IdType="pmc">PMC7844946</ArticleId><ArticleId IdType="pubmed">33509204</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarlinton R.E., Martynova E., Rizvanov A.A., Khaiboullina S., Verma S. Role of Viruses in the Pathogenesis of Multiple Sclerosis. Viruses. 2020;12:643. doi: 10.3390/v12060643.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12060643</ArticleId><ArticleId IdType="pmc">PMC7354629</ArticleId><ArticleId IdType="pubmed">32545816</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Million M., Dudouet P., Tissot-Dupont H., Bregeon F., Cammilleri S., Raoult D. (18)F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: Substrate for persistent/delayed disorders? Eur. J. Nucl. Med. Mol. Imaging. 2021;48:592&#x2013;595. doi: 10.1007/s00259-020-04973-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-04973-x</ArticleId><ArticleId IdType="pmc">PMC7391029</ArticleId><ArticleId IdType="pubmed">32728799</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J.M., Tan B.H., Wu S., Gui Y., Suo J.L., Li Y.C. Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection. J. Med. Virol. 2021;93:1304&#x2013;1313. doi: 10.1002/jmv.26570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26570</ArticleId><ArticleId IdType="pmc">PMC7537172</ArticleId><ArticleId IdType="pubmed">33002209</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis A., Frontera J., Placantonakis D.G., Lighter J., Galetta S., Balcer L., Melmed K.R. Cerebrospinal fluid in COVID-19: A systematic review of the literature. J. Neurol. Sci. 2021;421:117316. doi: 10.1016/j.jns.2021.117316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117316</ArticleId><ArticleId IdType="pmc">PMC7833669</ArticleId><ArticleId IdType="pubmed">33561753</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S.R., Ramelli S.C., Grazioli A., Chung J.Y., Singh M., Yinda C.K., Winkler C.W., Sun J., Dickey J.M., Ylaya K., et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;763. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Zhang C., Israelow B., Lu-Culligan A., Prado A.V., Skriabine S., Lu P., Weizman O.E., Liu F., Dai Y., et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med. 2021;218 doi: 10.1084/jem.20202135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202135</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Savitt A.G., Manimala S., White T., Fandaros M., Yin W., Duan H., Xu X., Geisbrecht B.V., Rubenstein D.A., Kaplan A.P., et al. SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems. Front. Immunol. 2021;12:767347. doi: 10.3389/fimmu.2021.767347.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.767347</ArticleId><ArticleId IdType="pmc">PMC8602850</ArticleId><ArticleId IdType="pubmed">34804054</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia H., Yue X., Lazartigues E. ACE2 mouse models: A toolbox for cardiovascular and pulmonary research. Nat. Commun. 2020;11:5165. doi: 10.1038/s41467-020-18880-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18880-0</ArticleId><ArticleId IdType="pmc">PMC7560817</ArticleId><ArticleId IdType="pubmed">33057007</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinnon K.H., 3rd, Leist S.R., Schafer A., Edwards C.E., Martinez D.R., Montgomery S.A., West A., Yount B.L., Jr., Hou Y.J., Adams L.E., et al. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature. 2020;586:560&#x2013;566. doi: 10.1038/s41586-020-2708-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2708-8</ArticleId><ArticleId IdType="pmc">PMC8034761</ArticleId><ArticleId IdType="pubmed">32854108</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao L., Deng W., Huang B., Gao H., Liu J., Ren L., Wei Q., Yu P., Xu Y., Qi F., et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature. 2020;583:830&#x2013;833. doi: 10.1038/s41586-020-2312-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2312-y</ArticleId><ArticleId IdType="pubmed">32380511</ArticleId></ArticleIdList></Reference><Reference><Citation>Yinda C.K., Port J.R., Bushmaker T., Offei Owusu I., Purushotham J.N., Avanzato V.A., Fischer R.J., Schulz J.E., Holbrook M.G., Hebner M.J., et al. K18-hACE2 mice develop respiratory disease resembling severe COVID-19. PLoS Pathog. 2021;17:e1009195. doi: 10.1371/journal.ppat.1009195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009195</ArticleId><ArticleId IdType="pmc">PMC7875348</ArticleId><ArticleId IdType="pubmed">33465158</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S.H., Chen Q., Gu H.J., Yang G., Wang Y.X., Huang X.Y., Liu S.S., Zhang N.N., Li X.F., Xiong R., et al. A Mouse Model of SARS-CoV-2 Infection and Pathogenesis. Cell Host Microbe. 2020;28:124&#x2013;133 e124. doi: 10.1016/j.chom.2020.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.05.020</ArticleId><ArticleId IdType="pmc">PMC7250783</ArticleId><ArticleId IdType="pubmed">32485164</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong W., Mead H., Tian L., Park J.G., Garcia J.I., Jaramillo S., Barr T., Kollath D.S., Coyne V.K., Stone N.E., et al. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus. J. Virol. 2022;96:e0096421. doi: 10.1128/JVI.00964-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00964-21</ArticleId><ArticleId IdType="pmc">PMC8754221</ArticleId><ArticleId IdType="pubmed">34668775</ArticleId></ArticleIdList></Reference><Reference><Citation>Carossino M., Kenney D., O&#x2019;Connell A.K., Montanaro P., Tseng A.E., Gertje H.P., Grosz K.A., Ericsson M., Huber B.R., Kurnick S.A., et al. Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression. Viruses. 2022;14:535. doi: 10.3390/v14030535.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14030535</ArticleId><ArticleId IdType="pmc">PMC8955233</ArticleId><ArticleId IdType="pubmed">35336942</ArticleId></ArticleIdList></Reference><Reference><Citation>Parekh R.U., Robidoux J., Sriramula S. Kinin B1 Receptor Blockade Prevents Angiotensin II-induced Neuroinflammation and Oxidative Stress in Primary Hypothalamic Neurons. Cell Mol. Neurobiol. 2020;40:845&#x2013;857. doi: 10.1007/s10571-019-00778-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-019-00778-1</ArticleId><ArticleId IdType="pmc">PMC8112717</ArticleId><ArticleId IdType="pubmed">31865500</ArticleId></ArticleIdList></Reference><Reference><Citation>Akula S.M., Bolin P., Cook P.P. Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating nsp10 gene. RNA Biol. 2022;19:1&#x2013;11. doi: 10.1080/15476286.2021.2010959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2021.2010959</ArticleId><ArticleId IdType="pmc">PMC8786335</ArticleId><ArticleId IdType="pubmed">34904915</ArticleId></ArticleIdList></Reference><Reference><Citation>Young K., Morrison H. Quantifying Microglia Morphology from Photomicrographs of Immunohistochemistry Prepared Tissue Using ImageJ. J. Vis. Exp. 2018:h. doi: 10.3791/57648.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/57648</ArticleId><ArticleId IdType="pmc">PMC6103256</ArticleId><ArticleId IdType="pubmed">29939190</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison H., Young K., Qureshi M., Rowe R.K., Lifshitz J. Quantitative microglia analyses reveal diverse morphologic responses in the rat cortex after diffuse brain injury. Sci. Rep. 2017;7:13211. doi: 10.1038/s41598-017-13581-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-13581-z</ArticleId><ArticleId IdType="pmc">PMC5643511</ArticleId><ArticleId IdType="pubmed">29038483</ArticleId></ArticleIdList></Reference><Reference><Citation>Parekh R.U., Sriramula S. Activation of Kinin B1R Upregulates ADAM17 and Results in ACE2 Shedding in Neurons. Int. J. Mol. Sci. 2020;22:145. doi: 10.3390/ijms22010145.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22010145</ArticleId><ArticleId IdType="pmc">PMC7795389</ArticleId><ArticleId IdType="pubmed">33375653</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriramula S., Lazartigues E. Kinin B1 Receptor Promotes Neurogenic Hypertension Through Activation of Centrally Mediated Mechanisms. Hypertension. 2017;70:1122&#x2013;1131. doi: 10.1161/HYPERTENSIONAHA.117.09744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.117.09744</ArticleId><ArticleId IdType="pmc">PMC5680117</ArticleId><ArticleId IdType="pubmed">29038201</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazdyrev E., Rusina P., Panova M., Novikov F., Grishagin I., Nebolsin V. Lung Fibrosis after COVID-19: Treatment Prospects. Pharmaceuticals. 2021;14:807. doi: 10.3390/ph14080807.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph14080807</ArticleId><ArticleId IdType="pmc">PMC8398080</ArticleId><ArticleId IdType="pubmed">34451904</ArticleId></ArticleIdList></Reference><Reference><Citation>John A.E., Joseph C., Jenkins G., Tatler A.L. COVID-19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts. Immunol. Rev. 2021;302:228&#x2013;240. doi: 10.1111/imr.12977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12977</ArticleId><ArticleId IdType="pmc">PMC8237078</ArticleId><ArticleId IdType="pubmed">34028807</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon-Rodriguez A., Fernandez-Arjona M.D.M., Grondona J.M., Pedraza C., Lopez-Avalos M.D. Anxiety-like behavior and microglial activation in the amygdala after acute neuroinflammation induced by microbial neuraminidase. Sci. Rep. 2022;12:11581. doi: 10.1038/s41598-022-15617-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15617-5</ArticleId><ArticleId IdType="pmc">PMC9270343</ArticleId><ArticleId IdType="pubmed">35803999</ArticleId></ArticleIdList></Reference><Reference><Citation>Golden J.W., Cline C.R., Zeng X., Garrison A.R., Carey B.D., Mucker E.M., White L.E., Shamblin J.D., Brocato R.L., Liu J., et al. Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease. JCI Insight. 2020;5 doi: 10.1172/jci.insight.142032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.142032</ArticleId><ArticleId IdType="pmc">PMC7566707</ArticleId><ArticleId IdType="pubmed">32841215</ArticleId></ArticleIdList></Reference><Reference><Citation>Oladunni F.S., Park J.G., Pino P.A., Gonzalez O., Akhter A., Allue-Guardia A., Olmo-Fontanez A., Gautam S., Garcia-Vilanova A., Ye C., et al. Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice. Nat. Commun. 2020;11:6122. doi: 10.1038/s41467-020-19891-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19891-7</ArticleId><ArticleId IdType="pmc">PMC7705712</ArticleId><ArticleId IdType="pubmed">33257679</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Castaneda A., Lu P., Geraghty A.C., Song E., Lee M.H., Wood J., Yalcin B., Taylor K.R., Dutton S., Acosta-Alvarez L., et al. Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain. bioRxiv. :2022. doi: 10.1101/2022.01.07.475453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.07.475453</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari P., Rothan H.A., Natekar J.P., Stone S., Pathak H., Strate P.G., Arora K., Brinton M.A., Kumar M. Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice. Viruses. 2021;13:132. doi: 10.3390/v13010132.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13010132</ArticleId><ArticleId IdType="pmc">PMC7832889</ArticleId><ArticleId IdType="pubmed">33477869</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein R., Soung A., Sissoko C., Nordvig A., Canoll P., Mariani M., Jiang X., Bricker T., Goldman J., Rosoklija G., et al. COVID-19 induces neuroinflammation and loss of hippocampal neurogenesis. Res. Sq. :2021. doi: 10.21203/rs.3.rs-1031824/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1031824/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Philippens I., Boszormenyi K.P., Wubben J.A.M., Fagrouch Z.C., van Driel N., Mayenburg A.Q., Lozovagia D., Roos E., Schurink B., Bugiani M., et al. Brain Inflammation and Intracellular alpha-Synuclein Aggregates in Macaques after SARS-CoV-2 Infection. Viruses. 2022;14:776. doi: 10.3390/v14040776.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14040776</ArticleId><ArticleId IdType="pmc">PMC9025893</ArticleId><ArticleId IdType="pubmed">35458506</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkai I., Mayer M.G., Hellmers L.M., Ning B., Huang Z., Monjure C.J., Coyne C., Silvestri R., Golden N., Hensley K., et al. Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat. Commun. 2022;13:1745. doi: 10.1038/s41467-022-29440-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29440-z</ArticleId><ArticleId IdType="pmc">PMC8975902</ArticleId><ArticleId IdType="pubmed">35365631</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Yang W., Chen F., Cui L. COVID-19 and cognitive impairment: Neuroinvasive and blood&#x2014;brain barrier dysfunction. J. Neuroinflamm. 2022;19:222. doi: 10.1186/s12974-022-02579-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02579-8</ArticleId><ArticleId IdType="pmc">PMC9450840</ArticleId><ArticleId IdType="pubmed">36071466</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S., Haferkamp U., Pfefferle S., Woo M.S., Heinrich F., Schweizer M., Appelt-Menzel A., Cubukova A., Barenberg J., Leu J., et al. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. Stem Cell Rep. 2022;17:307&#x2013;320. doi: 10.1016/j.stemcr.2021.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.12.011</ArticleId><ArticleId IdType="pmc">PMC8772030</ArticleId><ArticleId IdType="pubmed">35063125</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao J., Woodley C., Chao L., Margolius H.S. Identification of tissue kallikrein in brain and in the cell-free translation product encoded by brain mRNA. J. Biol. Chem. 1983;258:15173&#x2013;15178. doi: 10.1016/S0021-9258(17)43789-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)43789-6</ArticleId><ArticleId IdType="pubmed">6558077</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert-Weissenberger C., Stetter C., Meuth S.G., Gobel K., Bader M., Siren A.L., Kleinschnitz C. Blocking of bradykinin receptor B1 protects from focal closed head injury in mice by reducing axonal damage and astroglia activation. J. Cereb. Blood Flow Metab. 2012;32:1747&#x2013;1756. doi: 10.1038/jcbfm.2012.62.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2012.62</ArticleId><ArticleId IdType="pmc">PMC3434625</ArticleId><ArticleId IdType="pubmed">22569191</ArticleId></ArticleIdList></Reference><Reference><Citation>Raslan F., Schwarz T., Meuth S.G., Austinat M., Bader M., Renne T., Roosen K., Stoll G., Siren A.L., Kleinschnitz C. Inhibition of bradykinin receptor B1 protects mice from focal brain injury by reducing blood-brain barrier leakage and inflammation. J. Cereb. Blood Flow Metab. 2010;30:1477&#x2013;1486. doi: 10.1038/jcbfm.2010.28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2010.28</ArticleId><ArticleId IdType="pmc">PMC2949241</ArticleId><ArticleId IdType="pubmed">20197781</ArticleId></ArticleIdList></Reference><Reference><Citation>Trabold R., Eros C., Zweckberger K., Relton J., Beck H., Nussberger J., Muller-Esterl W., Bader M., Whalley E., Plesnila N. The role of bradykinin B(1) and B(2) receptors for secondary brain damage after traumatic brain injury in mice. J. Cereb. Blood Flow Metab. 2010;30:130&#x2013;139. doi: 10.1038/jcbfm.2009.196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2009.196</ArticleId><ArticleId IdType="pmc">PMC2949094</ArticleId><ArticleId IdType="pubmed">19773800</ArticleId></ArticleIdList></Reference><Reference><Citation>Witcher K.G., Bray C.E., Chunchai T., Zhao F., O&#x2019;Neil S.M., Gordillo A.J., Campbell W.A., McKim D.B., Liu X., Dziabis J.E., et al. Traumatic Brain Injury Causes Chronic Cortical Inflammation and Neuronal Dysfunction Mediated by Microglia. J. Neurosci. 2021;41:1597&#x2013;1616. doi: 10.1523/JNEUROSCI.2469-20.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2469-20.2020</ArticleId><ArticleId IdType="pmc">PMC7896020</ArticleId><ArticleId IdType="pubmed">33452227</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoogland I.C., Houbolt C., van Westerloo D.J., van Gool W.A., van de Beek D. Systemic inflammation and microglial activation: Systematic review of animal experiments. J. Neuroinflamm. 2015;12:114. doi: 10.1186/s12974-015-0332-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0332-6</ArticleId><ArticleId IdType="pmc">PMC4470063</ArticleId><ArticleId IdType="pubmed">26048578</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham C., Campion S., Teeling J., Felton L., Perry V.H. The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C) Brain Behav. Immun. 2007;21:490&#x2013;502. doi: 10.1016/j.bbi.2006.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2006.12.007</ArticleId><ArticleId IdType="pubmed">17321719</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrar B., Al-Doaiss A., Shati A., Al-Kahtani M., Jarrar Q. Behavioural alterations induced by chronic exposure to 10 nm silicon dioxide nanoparticles. IET Nanobiotechnol. 2021;15:221&#x2013;235. doi: 10.1049/nbt2.12041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1049/nbt2.12041</ArticleId><ArticleId IdType="pmc">PMC8675786</ArticleId><ArticleId IdType="pubmed">34694701</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Chen M., Feng X., Song M., Shao M., Yang Y., Zhang L., Liu Q., Lv L., Su X. Maternal immune activation alters adult behavior, intestinal integrity, gut microbiota and the gut inflammation. Brain Behav. 2021;11:e02133. doi: 10.1002/brb3.2133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2133</ArticleId><ArticleId IdType="pmc">PMC8119836</ArticleId><ArticleId IdType="pubmed">33793085</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitanaka J., Kitanaka N., Hall F.S., Fujii M., Goto A., Kanda Y., Koizumi A., Kuroiwa H., Mibayashi S., Muranishi Y., et al. Memory impairment and reduced exploratory behavior in mice after administration of systemic morphine. J. Exp. Neurosci. 2015;9:27&#x2013;35. doi: 10.4137/JEN.S25057.</Citation><ArticleIdList><ArticleId IdType="doi">10.4137/JEN.S25057</ArticleId><ArticleId IdType="pmc">PMC4428380</ArticleId><ArticleId IdType="pubmed">25987850</ArticleId></ArticleIdList></Reference><Reference><Citation>Darwish B., Chamaa F., Al-Chaer E.D., Saade N.E., Abou-Kheir W. Intranigral Injection of Endotoxin Suppresses Proliferation of Hippocampal Progenitor Cells. Front. Neurosci. 2019;13:687. doi: 10.3389/fnins.2019.00687.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00687</ArticleId><ArticleId IdType="pmc">PMC6616074</ArticleId><ArticleId IdType="pubmed">31333405</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiss R., Grodzki D.M., Horger W., Uder M., Nagel A.M., Bickelhaupt S. High-performance low field MRI enables visualization of persistent pulmonary damage after COVID-19. Magn. Reson. Imaging. 2021;76:49&#x2013;51. doi: 10.1016/j.mri.2020.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mri.2020.11.004</ArticleId><ArticleId IdType="pmc">PMC7673210</ArticleId><ArticleId IdType="pubmed">33220447</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho J.L., Villacreses R., Nagpal P., Guo J., Pezzulo A.A., Thurman A.L., Hamzeh N.Y., Blount R.J., Fortis S., Hoffman E.A., et al. Quantitative Chest CT Assessment of Small Airways Disease in Post-Acute SARS-CoV-2 Infection. Radiology. 2022:212170. doi: 10.1148/radiol.212170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.212170</ArticleId><ArticleId IdType="pmc">PMC9270680</ArticleId><ArticleId IdType="pubmed">35289657</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M., Morbelli S., Ciccarelli M., Cecconi M., Aghemo A., Morelli P., Chiola S., Gelardi F., Chiti A. Long COVID hallmarks on [18F]FDG-PET/CT: A case-control study. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:3187&#x2013;3197. doi: 10.1007/s00259-021-05294-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05294-3</ArticleId><ArticleId IdType="pmc">PMC7937050</ArticleId><ArticleId IdType="pubmed">33677642</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetti F., Palladini M., Paolini M., Melloni E., Vai B., De Lorenzo R., Furlan R., Rovere-Querini P., Falini A., Mazza M.G. Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: A multimodal magnetic resonance imaging study. Brain Behav. Immun. Health. 2021;18:100387. doi: 10.1016/j.bbih.2021.100387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100387</ArticleId><ArticleId IdType="pmc">PMC8562046</ArticleId><ArticleId IdType="pubmed">34746876</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Al-Aly Z. Risks of mental health outcomes in people with covid-19: Cohort study. BMJ. 2022;376:e068993. doi: 10.1136/bmj-2021-068993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068993</ArticleId><ArticleId IdType="pmc">PMC8847881</ArticleId><ArticleId IdType="pubmed">35172971</ArticleId></ArticleIdList></Reference><Reference><Citation>Sy M., Kitazawa M., Medeiros R., Whitman L., Cheng D., Lane T.E., Laferla F.M. Inflammation induced by infection potentiates tau pathological features in transgenic mice. Am. J. Pathol. 2011;178:2811&#x2013;2822. doi: 10.1016/j.ajpath.2011.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2011.02.012</ArticleId><ArticleId IdType="pmc">PMC3124234</ArticleId><ArticleId IdType="pubmed">21531375</ArticleId></ArticleIdList></Reference><Reference><Citation>De Chiara G., Piacentini R., Fabiani M., Mastrodonato A., Marcocci M.E., Limongi D., Napoletani G., Protto V., Coluccio P., Celestino I., et al. Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice. PLoS Pathog. 2019;15:e10076117. doi: 10.1371/journal.ppat.1007617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007617</ArticleId><ArticleId IdType="pmc">PMC6417650</ArticleId><ArticleId IdType="pubmed">30870531</ArticleId></ArticleIdList></Reference><Reference><Citation>Engler-Chiurazzi E.B., Russell A.E., Povroznik J.M., McDonald K.O., Porter K.N., Wang D.S., Hammock J., Billig B.K., Felton C.C., Yilmaz A., et al. Intermittent systemic exposure to lipopolysaccharide-induced inflammation disrupts hippocampal long-term potentiation and impairs cognition in aging male mice. Brain Behav. Immun. 2023;108:279&#x2013;291. doi: 10.1016/j.bbi.2022.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.12.013</ArticleId><ArticleId IdType="pmc">PMC10019559</ArticleId><ArticleId IdType="pubmed">36549577</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>